Companies / Slovakia

Survey Reveals Unease Over Medicine Prices

September 2007 | Industry News

Printable version
Bookmark

A survey by Slovakia's MVK agency with a sample size of 1,200 adults has revealed that 80% of respondents believe that high pharmaceutical prices are the biggest problem facing the healthcare system.

To read the full article, please choose one of the following options:

Subcribers please log in

Related Insight Articles

2012 Outlook Maintained As Key Drug Policy Reforms Pass Parliament Before Government Falls

Industry / Slovakia BMI View: Our weak 2012 outlook for Slovakia's pharmaceutical market has been maintained with the passage of key drug policy reforms in September, prior to the fall of Iveta Radicová's government in early...

October 2011

Drug Pricing Pressures Will Continue To Limit Pharmaceutical Market Growth

Industry / Slovakia BMI View: Throughout 2009 and 2010, the Slovakian pharmaceutical market has faced considerable challenges in the form of government- imposed drug price controls and weakening domestic demand. In 2011 and...

November 2010

New Referencing Round Should Cause Further Price Erosion For Drugmakers

Industry / Slovakia The next update to Slovakia's medicine price list is due in April 2010, with the Ministry of Health aiming to reference 90% of marketed products. This update is expected to bring about savings of EUR30mn...

March 2010

Slovaks Staying With State Insurers

Companies / Slovakia The ratio of people who use state health insurers compered to private sector counterparts has remained relatively constant this year, according to the Health Care supervisory Office. The private sector...

October 2007

Governing Parties Agree Over Private Insurers

Industry / Slovakia The governing parties in the Slovakian government - the Slovak National Coalition (SNC), Sociálna Demokracia (Smer) and the LS-HZDS - have found common ground concerning the bill to amend the Health...

September 2007